Clinical Trials Logo

Clinical Trial Summary

Over the last decade, awareness of the effects of hydrocarbon fuels on neurodegenerative disorders has increased significantly, as they are ubiquitous environmentally toxic chemicals that affect the central nervous system and result in irreversible neuronal damage, as many hydrocarbons can cross the blood-brain barrier through multiple pathways and cause direct toxicity.


Clinical Trial Description

Petrol stations are establishments that retail liquid fuels derived from petroleum, alcohol, and other automotive fuels, with equipment available for their measurement and storage. This process, linked to gasoline distribution, can be a significant source of volatile organic compounds (VOCs), such as benzene, toluene, ethylbenzene, and xylene isomers (BTEX), the primary volatile hydrocarbons derived from petroleum. Headache, fatigue, dizziness, respiratory tract infections, skin allergies, eye infections, and impairment of memory have been experienced by a few people immediately following exposure to some solvents. CNS depression is a common physiological outcome caused by high exposure to some VOCs. General anaesthetic effects, and as a most severe outcome, unconsciousness and, in some cases, death, may occur at the end. Long-term exposure to organic solvents may cause permanent central nervous system disturbances, a condition called chronic solvent encephalopathy (CSE). Cognitive symptoms and neuropsychological signs, or issues with memory, focus, and learning, are the hallmarks of CSE, which is underdiagnosed and characterized by these symptoms as well as possible side effects like headaches, fatigue, balance issues, and mild depression. If exposure stops, though, the illness will not worsen. We are discovering more about the importance of nutrition and its impact on an individual's susceptibility to illness progression. Diet has been suggested to have an important role in cognitive health and the development of dementia. However, most of the intervention studies conducted to date have mainly assessed the effect of dietary supplements on cognitive function. The toxicity of inhaled vapours is due to their biotransformation into reactive oxygen species, and several studies have highlighted the capacity of whey protein to increase glutathione (GSH), suggesting that this complex mixture is capable of boosting GSH synthesis, thus reducing oxidative stress. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06380998
Study type Observational
Source Assiut University
Contact Gehad H Eisa, Assi. lectur
Phone +201018602754
Email gehadhussien552@gmail.com
Status Not yet recruiting
Phase
Start date October 1, 2024
Completion date October 1, 2027

See also
  Status Clinical Trial Phase
Completed NCT04138446 - Effects of Acute Hypobaric Hypoxia Exposure on Neurocognitive Performance of Pre-hospital Emergency Service Providers N/A
Recruiting NCT05497427 - Normative Database and Test-Retest Reliability for BrainCheck Assessments
Recruiting NCT06056934 - Pain Management in Elderly Patients With or Without Cognitive Frailty Hospitalized "ALGOGER"
Recruiting NCT04263194 - Network-based rTMS in Alzheimer's Disease N/A
Completed NCT02288221 - Safe & Easy Environment at Home for Patients Presenting a Frail Syndrome N/A
Completed NCT02518243 - Safe & Easy for Alzheimer's Disease and Related Pathologies N/A
Completed NCT01329653 - Exercise, Age-Related Memory Decline, And Hippocampal Function N/A
Recruiting NCT05728801 - Decoding the Cognitive Trajectory of Hong Kong SuperAgers: a Longitudinal Follow-up Study
Terminated NCT03032471 - Swiss SOS MoCA - DCI Study
Completed NCT05863065 - Personalized Virtual Reality Naturalistic Scenarios in Cognitive Impairment N/A
Recruiting NCT03657745 - Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy
Terminated NCT03353987 - Preoperative Cognitive Training for Postoperative Cognitive Dysfunction N/A
Completed NCT03246269 - Normative Values for the German Version of the Montreal Cognitive Assessment (MoCA)
Completed NCT02968992 - Effects of rhLactoferrin on Chronic Inflammation in the Elderly Phase 2
Not yet recruiting NCT06256666 - Objective Measurement of Pain in Individuals With Cognitive Deterioration Utilizing Electroencephalography
Active, not recruiting NCT05818423 - Brain Health Together: A Live-Streaming Group-Based Digital Program N/A